multiday continuous patch electrocardiographic monitor for the diagnosis of drug-refractory atrial fibrillation

Comparison between multiday continuous patch electrocardiographic monitor and 24-hour holter for the diagnosis of drug-refractory atrial fibrillation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006889

Enrollment

Registered

2022-01-05

Start date

2022-02-25

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This is a prospective, single-arm controlled trial. All enrolled patients receive long-term patch type ECG monitoring and 24-hr Holter test simultaneously. After 14 days, both device

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with atrial fibrillation who are in sinus rhythm after antiarrhythmic drug treatment for more than 6 weeks

Exclusion criteria

Exclusion criteria: 1) Persistent atrial fibrillation after 6 weeks of antiarrhythmic treatment 2) Difficult to understand study contents due to cognitive impairment

Design outcomes

Primary

Measure	Time frame
Detection rate of drug-refractory atrial fibrillation	—

Secondary

Measure	Time frame
detection rate of clinically significant arrhythmia other than atrial fibrillation (supraventricular tachycardia >30sec, sinus pause >3sec, 2nd or 3rd degree AV block, ventricular tachycardia)	—

Countries

Korea, Republic of

Contacts

Public ContactYoung Choi

The Catholic University of Korea, Seoul St. Mary's Hospital

coolnite0@gmail.com+82-2-1588-1511

Outcome results